R. Bigler

发表

Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations.

E. Vonderheid, M. Kadin, E. Vonderheid, 1990, Journal of the American Academy of Dermatology.

Variable CD 7 Expression on T Cells in the Leukemic Phase of Cutaneous T Cell Lymphoma ( SeÂzary Syndrome )

M. Polansky, S. Lessin, E. Vonderheid, 2010 .

V beta-specific stimulation of human T cells by staphylococcal toxins.

P. Marrack, E. Gelfand, J. Kappler, 1989, Science.

Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome.

E. Vonderheid, B. Foley, R. Bigler, 1996, The American journal of pathology.

Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).

E. Vonderheid, N. Jhala, F. Garcia, 2000, American journal of clinical pathology.

On the possible relationship between staphylococcal superantigens and increased Vβ5·1 usage in cutaneous T‐cell lymphoma

E. Vonderheid, R. Bigler, J. Hou, 2005, The British journal of dermatology.

L-DOPA: chemical modifications and biological evaluation.

A. Brossi, A. Kaiser, W. Pool, 1974, Advances in neurology.

Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes.

J. D. Baum, R. Bigler, S. Lund-Katz, 1993, Biochimica et biophysica acta.

Effect of lovastatin on cell surface expression of Fc receptors or CD14 antigen in human monocytes.

E. Gressen, R. Bigler, Mojtaba Esfahani, 1993, Biochemical pharmacology.

Diabetic nephropathy in a patient with maturity-onset diabetes of the young.

S. Adler, R. Bigler, 1981, Archives of internal medicine.

A Novel Disulfide-Linked Cell Surface Molecule Present on Resting and Activated Human T Lymphocytes

N. Chiorazzi, R. Bigler, 1986 .

Idiotype-like molecules on cells of a human T cell leukemia

C. Y. Wang, H. Kunkel, D. Fisher, 1983, The Journal of experimental medicine.

Potentiated lymphokine-activated killer cell activity generated by low-dose interleukin-2 and mismatched double-stranded RNA

R. Bigler, H. Hubbell, G. Gibson, 2005, Cancer Immunology, Immunotherapy.

Practical Flow Cytometry, Second Edition

R. Bigler, 1989 .

1452 RESTING T CELL ACTIVATION BY ANTIRECEPTOR

N. Chiorazzi, R. Bigler, D. Posnett, 2003 .

Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor

N. Chiorazzi, R. Bigler, D. Posnett, 1985, The Journal of experimental medicine.

Private and Shared Idiotypic Determinants of the Human T Cell Antigen Receptor

N. Chiorazzi, R. Bigler, 1986 .

T cell antiidiotypic antibodies reveal differences between two human leukemias

C. Y. Wang, H. Kunkel, D. Fisher, 1984, The Journal of experimental medicine.

Analysis of p53 and mdm‐2 expression in 18 patients with Sézary syndrome

D. Haines, D. Marks, D. Morgan, 1996, British journal of haematology.

Extracorporeal Photopheresis and Recombinant Interferon Alfa 2b in Sezary Syndrome: Use of Dual Marker Labeling to Monitor Therapeutic Response

E. Vonderheid, R. Bigler, B. Micaily, 1994, American journal of clinical oncology.

Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft

D. Strayer, E. Pequignot, R. Bigler, 2005, Cancer Immunology, Immunotherapy.

Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.

M. Wasik, M. Polansky, S. Lessin, 1998, Journal of the American Academy of Dermatology.

Evidence for restricted Vβ usage in the leukemic phase of cutaneous T cell lymphoma

E. Vonderheid, R. Bigler, M. Conroy, 2005 .

Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.

R. Bigler, S. Lund-Katz, L. Scerbo, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.

E. Vonderheid, M. Wasik, M. Polansky, 1996, Archives of dermatology.

High spinal anesthesia in an infant.

R. Bigler, R. Valley, A. Bailey, 1989, Anesthesiology.

Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes.

J. Silver, R. Pergolizzi, R. Bigler, 1993, Journal of immunology.

Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).

M. Polansky, S. Lessin, E. Vonderheid, 2001, The Journal of investigative dermatology.

Effect of extracorporeal photopheresis on selected immunologic parameters in psoriasis vulgaris.

E. Vonderheid, M. Kadin, E. Vonderheid, 1989, The Yale journal of biology and medicine.

Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.

E. Vonderheid, R. Bigler, M. Conroy, 2005, The Journal of investigative dermatology.

The Acute Leukemias: Biologic, Diagnostic, and Therapeutic Determinants

R. Bigler, 1988 .

S152 (CD27). A modulating disulfide-linked T cell activation antigen.

N. Chiorazzi, Y. Bushkin, R. Bigler, 1988, Journal of immunology.

Effect of low-density lipoprotein on the expression of high affinity Fcγ receptors

P. Guyre, R. Bigler, S. Lund-Katz, 1989 .

A comparison of low-power helium-cadmium and argon ultraviolet lasers in commercial flow cytometers.

R. Bigler, 1987, Cytometry.

Flow Cytometric Criteria for Lymph Node Ratings and Staging of Mycosis Fungoides and Sézary Syndrome

E. Vonderheid, R. Bigler, J. Hou, 2019 .